Page last updated: 2024-11-05

1,8-naphthalenedicarboxylic acid anhydride

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

1,8-Naphthalenedicarboxylic acid anhydride is a white, crystalline solid. It is an important intermediate in the synthesis of various organic compounds, including dyes, polymers, and pharmaceuticals. The compound can be synthesized by the oxidation of 1,8-naphthalene using potassium permanganate or chromic acid. 1,8-Naphthalenedicarboxylic acid anhydride is also used as a catalyst in various organic reactions, such as the Diels-Alder reaction. Its unique structure, with two carboxylic acid groups attached to a naphthalene ring, makes it a versatile building block for various chemical transformations. Research on this compound focuses on exploring its potential applications in material science, particularly in the development of new polymers with improved properties. The compound is also being investigated for its potential as a precursor for the synthesis of novel pharmaceuticals.'

1,8-naphthalenedicarboxylic acid anhydride: used as seed protector from herbicides [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID6693
CHEMBL ID316059
CHEBI ID82246
SCHEMBL ID30415
MeSH IDM0059582

Synonyms (72)

Synonym
AC-19760
chebi:82246 ,
CHEMBL316059 ,
benzo[de]isochromene-1,3-dione
protect
naphthalic anhydride
naphthalic acid anhydride
1,8-naphthalic anhydride
1,8-naphthalic acid anhydride
naphthalene-1,8-dicarboxylic acid anhydride
nsc-5747
wln: t666 1a m cvovj
nsc5747
81-84-5
1h,8-cd]pyran-1,3-dione
1,8-naphthalenedicarboxylic anhydride
1,8-naphthalenedicarboxylic acid anhydride
1h,3h-naphtho[1,8-cd]pyran-1,3-dione
inchi=1/c12h6o3/c13-11-8-5-1-3-7-4-2-6-9(10(7)8)12(14)15-11/h1-6
brn 0153190
ai3-09071
einecs 201-380-2
1h,3h-naphtho(1,8-cd)pyran-1,3-dione
protect (agrochemical)
hsdb 7371
nsc 5747
pakarli
naphthalene-1,8-dicarboxylic anhydride
1h,3h-benzo[de]isochromene-1,3-dione
AK-968/40208880
STK301830
bdbm50146058
N0022
AKOS000119799
NCGC00248503-01
32rs852x55 ,
5-17-11-00492 (beilstein handbook reference)
ec 201-380-2
unii-32rs852x55
1,8-naphthalene dicarboxylic acid
C19125
cas-81-84-5
NCGC00257599-01
dtxcid606505
dtxsid4026505 ,
tox21_200045
naphtho[1,8,8a-c,d]pyran-1,3-dione
BBL013053
naphthalenedicarboxylic anhydride
34314-32-4
FT-0607054
3-oxatricyclo[7.3.1.0^{5,13}]trideca-1(13),5,7,9,11-pentaene-2,4-dione
1,8-naphthalene dicarboxylic anhydride
3-oxatricyclo[7.3.1.0?,??]trideca-1(13),5,7,9,11-pentaene-2,4-dione
SCHEMBL30415
PS-4566
naphthalenedicarboxylic-1,8-anhydride
1,8-naphthoic anhydride
1,8-naphthanoic anhydride
1h,3h-benzo[de]isochromene-1,3-dione #
Q-200092
STR00696
F0001-2093
mfcd00006925
3-oxatricyclo[7.3.1.0,]trideca-1(13),5,7,9,11-pentaene-2,4-dione
Q424800
3-oxatricyclo[7.3.1.0,5,13]trideca-1(13),5,7,9,11-pentaene-2,4-dione
EN300-19615
E78956
3-oxatricyclo[7.3.1.05,13]trideca-1(12),5,7,9(13),10-pentaene-2,4-dione
PD119237
Z104474468

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" The fungicides captan and thiram were the most toxic among the compounds tested."( 1,8-Naphthalic anhydride antidote enhances the toxic effects of captan and thiram fungicides on Azospirillum brasilense cells.
Casalone, E; Colella, CM; Daly, S; Gallori, E; Polsinelli, M,
)
0.13
"In plants potentially toxic compounds are ultimately deposited in the large central vacuole."( A herbicide antidote (safener) induces the activity of both the herbicide detoxifying enzyme and of a vacuolar transporter for the detoxified herbicide.
Amrhein, N; Dufaud, A; Gaillard, C; Kreuz, K; Martinoia, E; Tommasini, R, 1994
)
0.29

Bioavailability

ExcerptReferenceRelevance
"To increase the bioavailability of plant protection products, we have applied a new approach based on noncovalent association with natural water-soluble polysaccharides and oligosaccharides as delivery systems (DSs)."( Natural Poly- and Oligosaccharides as Novel Delivery Systems for Plant Protection Compounds.
Apanasenko, IE; Khalikov, SS; Polyakov, NE; Selyutina, OY, 2017
)
0.46
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
cyclic dicarboxylic anhydrideAn acid anhydride derived by loss of water between two carboxylic groups in the same molecule so as to close a ring.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (14)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
RAR-related orphan receptor gammaMus musculus (house mouse)Potency30.91850.006038.004119,952.5996AID1159521; AID1159523
AR proteinHomo sapiens (human)Potency54.98170.000221.22318,912.5098AID1259247
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency17.88370.003041.611522,387.1992AID1159552; AID1159555
pregnane X nuclear receptorHomo sapiens (human)Potency19.50820.005428.02631,258.9301AID1346982
aryl hydrocarbon receptorHomo sapiens (human)Potency43.29860.000723.06741,258.9301AID743085; AID743122
thyroid stimulating hormone receptorHomo sapiens (human)Potency15.95510.001628.015177.1139AID1224843; AID1224895
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_aHomo sapiens (human)Potency9.861019.739145.978464.9432AID1159509
v-jun sarcoma virus 17 oncogene homolog (avian)Homo sapiens (human)Potency15.08450.057821.109761.2679AID1159526; AID1159528
Histone H2A.xCricetulus griseus (Chinese hamster)Potency116.26900.039147.5451146.8240AID1224845; AID1224896
thyroid hormone receptor beta isoform 2Rattus norvegicus (Norway rat)Potency16.65950.000323.4451159.6830AID743065; AID743067
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency2.45590.000627.21521,122.0200AID743202; AID743219
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Thymidylate synthaseHomo sapiens (human)Ki2.00000.00010.34353.0000AID725769
NAD-dependent histone deacetylase SIR2Saccharomyces cerevisiae S288CIC50 (µMol)8.80008.80008.80008.8000AID204971
Thymidylate synthaseEscherichia coli K-12Ki294.00000.03000.54154.7000AID725776
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
NAD-dependent histone deacetylase SIR2Saccharomyces cerevisiae S288CInhibition0.94000.15000.67600.9400AID204972
NAD-dependent histone deacetylase SIR2Saccharomyces cerevisiae S288CMGC150.00000.49000.67000.8500AID204973
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (24)

Processvia Protein(s)Taxonomy
dTMP biosynthetic processThymidylate synthaseHomo sapiens (human)
dTTP biosynthetic processThymidylate synthaseHomo sapiens (human)
circadian rhythmThymidylate synthaseHomo sapiens (human)
response to xenobiotic stimulusThymidylate synthaseHomo sapiens (human)
response to toxic substanceThymidylate synthaseHomo sapiens (human)
negative regulation of translationThymidylate synthaseHomo sapiens (human)
uracil metabolic processThymidylate synthaseHomo sapiens (human)
methylationThymidylate synthaseHomo sapiens (human)
response to progesteroneThymidylate synthaseHomo sapiens (human)
response to vitamin AThymidylate synthaseHomo sapiens (human)
response to cytokineThymidylate synthaseHomo sapiens (human)
tetrahydrofolate interconversionThymidylate synthaseHomo sapiens (human)
response to ethanolThymidylate synthaseHomo sapiens (human)
response to organophosphorusThymidylate synthaseHomo sapiens (human)
developmental growthThymidylate synthaseHomo sapiens (human)
cartilage developmentThymidylate synthaseHomo sapiens (human)
response to glucocorticoidThymidylate synthaseHomo sapiens (human)
response to folic acidThymidylate synthaseHomo sapiens (human)
intestinal epithelial cell maturationThymidylate synthaseHomo sapiens (human)
DNA biosynthetic processThymidylate synthaseHomo sapiens (human)
liver regenerationThymidylate synthaseHomo sapiens (human)
dTMP biosynthetic processThymidylate synthaseEscherichia coli K-12
response to radiationThymidylate synthaseEscherichia coli K-12
dTMP biosynthetic processThymidylate synthaseEscherichia coli K-12
dTTP biosynthetic processThymidylate synthaseEscherichia coli K-12
regulation of translationThymidylate synthaseEscherichia coli K-12
nucleotide biosynthetic processThymidylate synthaseEscherichia coli K-12
methylationThymidylate synthaseEscherichia coli K-12
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (8)

Processvia Protein(s)Taxonomy
mRNA regulatory element binding translation repressor activityThymidylate synthaseHomo sapiens (human)
thymidylate synthase activityThymidylate synthaseHomo sapiens (human)
folic acid bindingThymidylate synthaseHomo sapiens (human)
protein homodimerization activityThymidylate synthaseHomo sapiens (human)
sequence-specific mRNA bindingThymidylate synthaseHomo sapiens (human)
magnesium ion bindingThymidylate synthaseEscherichia coli K-12
RNA bindingThymidylate synthaseEscherichia coli K-12
thymidylate synthase activityThymidylate synthaseEscherichia coli K-12
methyltransferase activityThymidylate synthaseEscherichia coli K-12
protein homodimerization activityThymidylate synthaseEscherichia coli K-12
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (6)

Processvia Protein(s)Taxonomy
nucleusThymidylate synthaseHomo sapiens (human)
cytoplasmThymidylate synthaseHomo sapiens (human)
mitochondrionThymidylate synthaseHomo sapiens (human)
mitochondrial inner membraneThymidylate synthaseHomo sapiens (human)
mitochondrial matrixThymidylate synthaseHomo sapiens (human)
cytosolThymidylate synthaseHomo sapiens (human)
mitochondrionThymidylate synthaseHomo sapiens (human)
cytosolThymidylate synthaseHomo sapiens (human)
cytoplasmThymidylate synthaseEscherichia coli K-12
cytosolThymidylate synthaseEscherichia coli K-12
cytosolThymidylate synthaseEscherichia coli K-12
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (9)

Assay IDTitleYearJournalArticle
AID204972In vitro inhibition of sirtuin 2 was evaluated using yeast whole cell lysates at 75 uM2004Journal of medicinal chemistry, May-06, Volume: 47, Issue:10
Inhibitors of Sir2: evaluation of splitomicin analogues.
AID204973Sirtuin 2 inhibitory activity and was reported as minimum growth-stimulating concentration in Saccharomyces cerevisiae2004Journal of medicinal chemistry, May-06, Volume: 47, Issue:10
Inhibitors of Sir2: evaluation of splitomicin analogues.
AID1541972Selectivity index, ratio of IC50 for African green monkey Vero cells to IC50 for D-sorbitol synchronized ring stage of chloroquine-resistant Plasmodium falciparum W22020ACS medicinal chemistry letters, Feb-13, Volume: 11, Issue:2
Functionalized Naphthalimide-4-aminoquinoline Conjugates as Promising Antiplasmodials, with Mechanistic Insights.
AID725776Inhibition of Escherichia coli thymidylate synthase A2013Bioorganic & medicinal chemistry letters, Feb-01, Volume: 23, Issue:3
Ligand-based discovery of N-(1,3-dioxo-1H,3H-benzo[de]isochromen-5-yl)-carboxamide and sulfonamide derivatives as thymidylate synthase A inhibitors.
AID1541971Cytotoxicity against African green monkey Vero cells measured after 24 hrs by resazurin dye based fluorescence assay2020ACS medicinal chemistry letters, Feb-13, Volume: 11, Issue:2
Functionalized Naphthalimide-4-aminoquinoline Conjugates as Promising Antiplasmodials, with Mechanistic Insights.
AID1541970Antiplasmodial activity against D-sorbitol synchronized ring stage of chloroquine-resistant Plasmodium falciparum W2 assessed as parasite growth inhibition measured after 48 hrs by YOYO-1 dye based FACSort flow cytometry analysis2020ACS medicinal chemistry letters, Feb-13, Volume: 11, Issue:2
Functionalized Naphthalimide-4-aminoquinoline Conjugates as Promising Antiplasmodials, with Mechanistic Insights.
AID725773Inhibition of Escherichia coli thymidylate synthase A at 60 uM2013Bioorganic & medicinal chemistry letters, Feb-01, Volume: 23, Issue:3
Ligand-based discovery of N-(1,3-dioxo-1H,3H-benzo[de]isochromen-5-yl)-carboxamide and sulfonamide derivatives as thymidylate synthase A inhibitors.
AID725769Inhibition of human thymidylate synthase A2013Bioorganic & medicinal chemistry letters, Feb-01, Volume: 23, Issue:3
Ligand-based discovery of N-(1,3-dioxo-1H,3H-benzo[de]isochromen-5-yl)-carboxamide and sulfonamide derivatives as thymidylate synthase A inhibitors.
AID204971In vitro inhibition of sirtuin 2 was evaluated using yeast whole cell lysates2004Journal of medicinal chemistry, May-06, Volume: 47, Issue:10
Inhibitors of Sir2: evaluation of splitomicin analogues.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (19)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's4 (21.05)18.2507
2000's5 (26.32)29.6817
2010's9 (47.37)24.3611
2020's1 (5.26)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.68

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.68 (24.57)
Research Supply Index3.09 (2.92)
Research Growth Index4.77 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.68)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (4.76%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other20 (95.24%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]